Evidence map›Paper›PMID 35835004›Full record

ArticlePathobiology : journal of immunopathology, molecular and cellular biology2023

Interstitial Pulmonary Fibrosis and Extensive Dendriform Ossification with Persistent Viral Load: A Rare Presentation of Post-COVID-19 Condition in Need of Lung Transplantation.

Jasmin Dionne Haslbauer, Ivana Bratic-Hench, Katharina Cima, Anna Katharina Luger, Katja Schmitz, Florian Augustin, Christoph Krapf, Daniel Hoefer, Ivan Tancevski, Alexandar Tzankov and 1 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Pathobiology : journal of immunopathology, molecular and cellular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jasmin Dionne HaslbauerPathology, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland, jasmindionne.haslbauer@usb.ch.
Ivana Bratic-HenchPathology, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Katharina CimaDepartment of Internal Medicine II (Infectiology, Rheumatology, Pneumology), Medical University of Innsbruck, Innsbruck, Austria.
Anna Katharina LugerDivision of Radiology, University Hospital of Innsbruck, Innsbruck, Austria.
Katja SchmitzInstitute of Pathology, Innpath, Tyrolean State Clinics, Innsbruck, Austria.
Florian AugustinDepartment of Visceral, Transplantation and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria.
Christoph KrapfDepartment of Thoracic and Cardiovascular Surgery, University Hospital Innsbruck, Innsbruck, Austria.
Daniel HoeferDepartment of Thoracic and Cardiovascular Surgery, University Hospital Innsbruck, Innsbruck, Austria.
Ivan TancevskiDepartment of Internal Medicine II (Infectiology, Rheumatology, Pneumology), Medical University of Innsbruck, Innsbruck, Austria.
Alexandar TzankovPathology, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Judith Löffler-RaggDepartment of Internal Medicine II (Infectiology, Rheumatology, Pneumology), Medical University of Innsbruck, Innsbruck, Austria.
Innsbruck Medical University · ATUniversity Hospital Innsbruck · ATUniversity Hospital of Basel · CHTyrolean Cancer Research Institute · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence, presentation, and predisposing factors of post-acute sequelae of COVID-19 (PASC) are currently poorly understood. Lung explants may provide a rare insight into terminal SARS-CoV-2-associated lung damage and its pathophysiology. A 62-year-old man presented with progressively worsening respiratory symptoms after recovering from mild COVID-19 3 months earlier. No underlying pulmonary comorbidities were reported. A chest CT revealed bilateral extensive ground-glass and reticular opacities, suspicious of pulmonary fibrosis. Despite initial high-dose glucocorticoid therapy, the interstitial lung disease progressed, and after exhausting all viable therapeutic options, bilateral lung transplantation was successfully conducted. Histological analysis revealed extensive end-stage interstitial fibrosis with diffuse dendriform ossification and bronchiolar and transitional cell metaplasia. Signs of interstitial remodeling such as an increased interstitial collagen deposition, a pathological accumulation of CD163+/CD206+ M2-polarized macrophages with an increased expression of phosphorylated ERK, and an increased density of CD105+ newly formed capillaries were observed. qRT-PCR and immunohistochemistry for SARS-CoV-2 N-protein in the endothelium of medium-sized vessels confirmed a persistence of SARS-CoV-2. Our findings highlight a highly unusual presentation of SARS-CoV-2-associated lung fibrosis, implying that incomplete viral clearance in the vascular compartment may play a vital pathophysiological role in the development of PASC.

Indexed as

LungLung Diseases, InterstitialOsteogenesisPost-Acute COVID-19 SyndromePulmonary FibrosisCOVID-19Disease ProgressionHumansLung TransplantationMaleMiddle AgedTreatment OutcomeViral LoadCOVID-19Dendriform pulmonary ossificationLung transplantPost-COVID-19Pulmonary fibrosisSARS-COV-2

Identifiers

PMID35835004
PMCPMC10129030
OpenAlexW4285495102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.